- Demonstrating Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies...
Empowering Women and Their Health in the Workplace at GJK Facility Services
In recognition of Breast Cancer Awareness Week, George Stamas, AM, Director of GJK Facility...
- Published in "Kidney 360" Magazine
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...
- ACROMETA seeks to unlock value from its disposal of Life Science Incubator Holdings Pte. Ltd. following a strategic review.
- ACROMETA's wholly-owned subsidiary has...
ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced...
As we enter the fourth quarter, the market buzzes with optimism. The U.S. Federal Reserve’s interest rate reduction, aimed at bolstering liquidity, has drawn...
- VLP-Polio Expected to Accelerate Development and Fill the Gap.
CanSino Biologics Inc. (CanSinoBIO or the Company) has announced a milestone in its fight against...
